BARDA Broad Agency Announcement (BAA)
Funds advanced medical countermeasure development in the United States across multiple national threat focus areas.
About
BARDA's Broad Agency Announcement is the authority's main advanced R&D solicitation for medical countermeasures in the United States. The current solicitation, BAA-23-100-SOL-00004, stays open through September 25, 2028 and covers 12 active areas of interest spanning CBRN vaccines and antivirals, antimicrobials, radiological and nuclear countermeasures, chemical and burn or blast countermeasures, …
BiotechDefenseMedtechSynthetic Biology
Each grant below is a distinct funding opportunity with its own eligibility, scope, and deliverables.